Germacrone Market, Global Outlook and Forecast 2024-2031

Report ID: 1067508 | Published Date: Jan 2025 | No. of Page: 79 | Base Year: 2024 | Rating: 5 | Webstory: Check our Web story

Germacrone, a major activity component found in Curcuma zedoaria oil product, shows anti-inflammatory, antiandrogenic, and antimicrobial activities.
This report contains market size and forecasts of Germacrone in global, including the following market information:
Global Germacrone Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Germacrone Market Sales, 2017-2022, 2023-2028, (Kg)
Global top five Germacrone companies in 2021 (%)
The global Germacrone market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Min Purity Less Than 98% Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Germacrone include Merck, LGC, TCI, United States Biological, Santa Cruz Biotechnology, Biosynth Carbosynth, BOC Sciences, Selleck Chemicals and Clearsynth, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Germacrone manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Germacrone Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Germacrone Market Segment Percentages, by Type, 2021 (%)
Min Purity Less Than 98%
Min Purity 98%-99%
Min Purity More Than 99%
Global Germacrone Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Germacrone Market Segment Percentages, by Application, 2021 (%)
Research
Medical
Global Germacrone Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Germacrone Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Germacrone revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Germacrone revenues share in global market, 2021 (%)
Key companies Germacrone sales in global market, 2017-2022 (Estimated), (Kg)
Key companies Germacrone sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Merck
LGC
TCI
United States Biological
Santa Cruz Biotechnology
Biosynth Carbosynth
BOC Sciences
Selleck Chemicals
Clearsynth
Adooq Bioscience
Target Molecule
J&K Scientific
Energy Chemical

Frequently Asked Questions
Germacrone Market In Global report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Germacrone Market In Global report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Germacrone Market In Global report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports